 |
Market Research Report
Consumer Health in Uruguay |
||||||
| Published by | Euromonitor International | Product code | 973649 | ||||
| Published | Content info | 90 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Consumer Health in Uruguay | ||
| Published: November 24, 2020 | Content info: 90 Pages |
|
Consumer health is expected to see slightly higher current value growth in 2020 than was seen in 2019, with COVID-19 expected to be one of the main factors dictating growth in Uruguay. While the COVID-19 outbreak in Uruguay had little impact in terms of infections and deaths due to the country's good healthcare system, locals' concern about their health remained high. The government did not impose very strict restrictions, instead suggesting a short quarantine from mid-March through the end of A...
Euromonitor International's Consumer Health in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
List OF CONTENTS AND TABLES
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
MARKET DATA
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
KEY DATA FINDINGS
2020 IMPACT
Consumers gravitate towards acetaminophen in 2020 due to initial government recommendations
Demand for adult and paediatric ibuprofen is moderated in 2020
Major players continue to lead analgesics in 2020, but spike of acetaminophen boosts Gramon Bago the most
RECOVERY AND OPPORTUNITIES
Potential to develop e-commerce over the forecast period
Ibuprofen set to remain most popular analgesic, but new product development will aid solid growth of acetaminophen
Agreements with mutual pharmacies set to intensify competitive landscape
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
COVID-19 increases demand for cough remedies in 2020
Medicated confectionery initially struggles under lockdown restrictions in 2020
Sanofi-Aventis Uruguay takes the lead in 2020 due to its well-known cough remedy brands
RECOVERY AND OPPORTUNITIES
Consumers are expected to continue gravitating towards well-established brand names over the forecast period
Demand for cough and cold remedies set to drive growth over the forecast period
Environmental changes set to contribute to growth of decongestants and antihistamines/allergy remedies (systemic)
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Rising stress levels cause digestive problems leading to increased demand for certain digestive remedies in 2020
Antacids and laxatives continue to represent majority of sales of digestive remedies
Teva maintains its lead in 2020 due to its natural profile that increasingly attracts consumers
RECOVERY AND OPPORTUNITIES
Over the forecast period increasingly stressful and busy lives of the working age will drive demand for digestive remedies
Low-priced effectiveness of rapid-action antacids expected to keep them in high demand over the forecast period
Trends driving demand for digestive remedies are unlikely to change, thus moderate-high growth is expected over the forecast period
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Economic uncertainty triggered by COVID-19 lowers consumption of dermatologicals in 2020 as consumers prioritise other consumer health categories
Wide availability allows topical antifungals to generate the most sales in 2020, while antipruritics gain momentum
Urufarma SA retains leadership of dermatologicals in Uruguay in 2020
RECOVERY AND OPPORTUNITIES
Rebound expected from 2021, although consumers are expected to remain focused on getting the best value for their money
E-commerce set to intensify competition and eliminate consumer discomfort with purchasing haemorrhoid treatments and vaginal antifungals
New product development expected to increase offering of value-added benefits over the forecast period
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Volume sales continue to decline, while value growth of wound care is moderated by the economic impact of COVID-19
Despite new legislation requiring vehicles to carry first aid kits, sales remain insignificant
Johnson & Johnson maintains its lead in 2020, but domestic player Laboratorio Apiter continues to increase its value share
RECOVERY AND OPPORTUNITIES
Private label expected to increase its presence over the forecast period
Players will need to innovate to maintain growth in a mature category
Players expected to continue investing in licensed cartoons to boost sales over the forecast period
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Demand for immunity positioned vitamins skyrockets as COVID-19 emerges in 2020
Vitamin C sees growth early in the pandemic but is hampered by shortages in March 2020
Bayer continues to lead vitamins in 2020 benefitting from the boom in demand for vitamin C and multivitamins
RECOVERY AND OPPORTUNITIES
Solid growth expected throughout the forecast period as consumers maintain a preventative approach to health with vitamins
E-commerce set to intensify competition over the forecast period
Social media set to continue generating consumer interest in vitamins and helping drive sales
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Consumption of dietary supplements increases in 2020 as consumers adopt preventative health approaches to protect themselves from COVID-19
Probiotic supplements used to support the digestive system continue to see strong growth in 2020
Sanofi-Aventis retains its lead in dietary supplements in 2020, while direct players intensify the competition
RECOVERY AND OPPORTUNITIES
Companies will have to adjust to long-term changes in the daily routines of Uruguayans over the forecast period
Protein supplements set to continue performing well and gaining a wider consumer base
Joint health concerns will support growth of glucosamine and collagen dietary supplements
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Concern over adequate nutritional diets supports growth of weight management and wellbeing in 2020
Supplement nutrition drinks drives growth in 2020
While Herbalife was able to maintain its lead, other players intensify the competition
RECOVERY AND OPPORTUNITIES
Over the forecast period supplement nutrition drinks will continue to drive growth
Direct sellers set to continue rapidly gaining ground from store-based players over the forecast period
Weight management and wellbeing products are expected to rise in tandem with efforts to alleviate obesity through better diets and more exercise
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
Sports nutrition benefits from widening consumer base in 2020
COVID-19 drives the development of e-commerce
Domestic brands come out on top in 2020 benefitting from more affordable prices
RECOVERY AND OPPORTUNITIES
Sports influencers set to continue driving awareness and demand for sports protein products over the forecast period
Strong growth supported by increasing distribution of sports nutrition in chained pharmacies as well as gyms, exercise centres and through online websites
The use of social media in sports nutrition will continue to be important for consumers and major players
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
More consumers turn towards herbal/traditional products in 2020 as they become aware of the potentially harmful effects of chemical-based products
Immunity positioned herbal/traditional products drive growth in 2020
Laboratorios Gautier maintains its lead in 2020, while other international players intensify the competition
RECOVERY AND OPPORTUNITIES
Increasing consumer awareness of herbal/traditional products set to drive growth over the forecast period
E-commerce expected to attract consumer interest through affordable prices
High growth for herbal/traditional dietary supplements expected due to growing interest of the elderly population
CATEGORY DATA
KEY DATA FINDINGS
2020 IMPACT
In 2020 COVID-19 fuels the growth of previously lacklustre paediatric cough/cold remedies, as well as paediatric vitamins and dietary supplements
Paediatric analgesics continue to grow, driven by the strong performance of paediatric acetaminophen which was initially recommend by the government for COVID-19
Bayer continues to lead paediatric vitamins and dietary supplements in 2020, experiencing an upturn from previously declining current value sales
RECOVERY AND OPPORTUNITIES
Over the forecast period slower but still solid growth is expected, with paediatric vitamins and dietary supplements set to lead the way
Demand for value-priced generic brands is set to increase over the forecast period
Healthier eating habits pose a hurdle to growth over the forecast period
CATEGORY DATA
Consumer Health in Colombia
Consumer Health in South Africa
Competitor Strategies in Consumer Health
Where Consumers Shop for Consumer Health
Consumer Health in Switzerland
Consumer Health in Austria
Consumer Health in Germany
Consumer Health in Argentina
Consumer Health in Vietnam
Consumer Health in Israel